Welcome to Khiron
KhironMed is the medical division of KHIRON Life Sciences Corporation, a leading, vertically integrated, international medical cannabis company with core operations in Latin America and Europe. We strongly believe in the role of medical cannabis to improve health-related quality of life of people. This is why our priority is to support patients through:
of high-quality pharmaceutical products.
of continuing medical cannabis education programs for healthcare professionals.
We stand for...
Project Twenty21

Khiron is the first and only Latin-American provider in Project Twenty21 in the UK.
Project Twenty21 is the first and largest medical cannabis patient registry in Europe
Project Twenty21 aims to enroll 20.000 patients by the end of 2021, creating the largest body of evidence for the effectiveness and tolerability of medical cannabis.
Project Twenty21 is enrolling patients who have been diagnosed with one of the following conditions:
Chronic Pain, Anxiety Disorder, Multiple Sclerosis, Tourette Syndrome, Post-Traumatic Stress Disorder (PTSD), Substance use disorder (as a harm reduction strategy)



What's new?
Our team of experts regularly informs you about
changes in the industry.

THE CBD-ILEMMA

A tale of two (cannabis) registries
Our partners
Our partners in UK